News

NuGen M.D. announces that it will be launching a needle-free injection device specifically designed for domesticated household pets.

NuGen M.D. is pleased to announce that all matters submitted to shareholders for approval as set out in detail in the Company’s management information circular dated May 17, 2022 were approved at the annual and special meeting of the shareholders of the Company held on June 17, 2022.

NuGen M.D., in collaboration with Unifire, Inc., submitted on June 14th, 2022, an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (“EUA”) of NuGen reusable needle-free jet injector (NFJI) systems.

NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company”), a leader in needle-free drug delivery, is pleased to announce the launch of a new online brand store for its InsuJetTM needle-free injection device.

NuGen selected Draganfly Inc. and Coldchain Delivery Systems, Inc. to provide drones and services for the delivery of InsuJet™, insulin, and other crucial medical supplies to Ukraine.

Kin Communications has joined forces with NuGen Medical Devices to raise funds in order to purchase insulin to be administered and delivered with NuGen M.D’s needle-free injection device also known as InsuJet™, to Ukrainian diabetics urgently in need of daily insulin injections to stay alive.

NuGen Medical Devices Inc. and Unifire, Inc. are pleased to announce they have entered into a Master Distribution and Marketing Agreement dated March 14 2022, whereas Unifire has been granted exclusive rights to sell NuGen M.D.’s needle-free injection device into various US Government agencies.

NuGen Medical Devices Inc. and Unifire, Inc. are pleased to announce they have entered into a Master Distribution and Marketing Agreement dated March 14 2022, whereas Unifire has been granted exclusive rights to sell NuGen M.D.’s needle-free injection device into various US Government agencies.

NuGen Medical Devices is pleased to announce that it has signed a 5-year distribution agreement (the “Agreement”) with Harrington Consultants Limited and its joint venture partner Al Mufid Pharmaceuticals (the “Kuwait Joint Venture” or the “Distributor”).

First self-administered, needle-free injection system approved by Health Canada gives access to safe, painless, cost-effective, and more sustainable drug delivery

NuGen and Khotwa Providing Access to Safe and Effective, Needle Free Injections to a World Plagued with Diabetes TORONTO, Ontario

TORONTO, November 16, 2021 (Newsfile Corp.) – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen MD” or the “Company”), a leader

TORONTO, November 8, 2021 (Newswire.com) – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen MD” or the “Company”), a leader in needle-free

Download PDF TORONTO, November 4, 2021 (Newswire.com) – NuGen Medical Devices Inc. (formerly BuzBuz Capital Corp.) (the “Company”), is pleased